Kaj Metsärinne

11.9k total citations · 1 hit paper
77 papers, 3.0k citations indexed

About

Kaj Metsärinne is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kaj Metsärinne has authored 77 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cardiology and Cardiovascular Medicine, 22 papers in Nephrology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kaj Metsärinne's work include Dialysis and Renal Disease Management (14 papers), Nitric Oxide and Endothelin Effects (9 papers) and Parathyroid Disorders and Treatments (9 papers). Kaj Metsärinne is often cited by papers focused on Dialysis and Renal Disease Management (14 papers), Nitric Oxide and Endothelin Effects (9 papers) and Parathyroid Disorders and Treatments (9 papers). Kaj Metsärinne collaborates with scholars based in Finland, United Kingdom and Japan. Kaj Metsärinne's co-authors include Frej Fyhrquist, Ilkka Tikkanen, F Fyhrquist, Outi Saijonmaa, Salim Yusuf, I. Tikkanen, Roland E. Schmieder, Leopoldo Soares Piegas, Helmut Schumacher and Koon Teo and has published in prestigious journals such as The Lancet, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Kaj Metsärinne

73 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

2008 1.0k citations Kaj Metsärinne et al. The Lancet profile →

Peers

Countries citing papers authored by Kaj Metsärinne

Since Specialization

Citations

This map shows the geographic impact of Kaj Metsärinne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaj Metsärinne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaj Metsärinne more than expected).

Fields of papers citing papers by Kaj Metsärinne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaj Metsärinne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaj Metsärinne. The network helps show where Kaj Metsärinne may publish in the future.

Co-authorship network of co-authors of Kaj Metsärinne

This figure shows the co-authorship network connecting the top 25 collaborators of Kaj Metsärinne. A scholar is included among the top collaborators of Kaj Metsärinne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaj Metsärinne. Kaj Metsärinne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chronic kidney disease stage is associated with the number of risk factors in type 2 diabetes patients (STages Of NEphropathy in type 2 diabetes and Heart Failure – STONE HF) 2023 ·Primary care diabetes ·Kaj Metsärinne, Mikko Pietilä, Ilkka Kantola, Lotta K. Stenman, (unknown), Lasse Ruokolainen, Leo Niskanen	2
2	Association between bone mineral metabolism and vascular calcification in end-stage renal disease 2022 ·BMC Nephrology ·(unknown), Niina Koivuviita, Marko Seppänen, Heikki Kröger, (unknown), Eliisa Löyttyniemi, Kaj Metsärinne	12
3	The majority of type 2 diabetic patients in Finnish primary care are at very high risk of cardiovascular events: A cross-sectional chart review study (STONE HF) 2021 ·Primary care diabetes ·Kaj Metsärinne, Mikko Pietilä, Ilkka Kantola, Lotta K. Stenman, (unknown), (unknown), Tuija Poussa, Leo Niskanen	4
4	Progression of Aortic Calcification in Stage 4–5 Chronic Kidney Disease Patients Transitioning to Dialysis and Transplantation 2021 ·Kidney & Blood Pressure Research ·(unknown), (unknown), Tapio Hellman, Niina Koivuviita, Kaj Metsärinne, Mikko J. Järvisalo	3
5	Quality of Life Is Associated with Cardiac Biomarkers, Echocardiographic Indices, and Mortality in CKD Stage 4–5 Patients Not on Dialysis 2020 ·Blood Purification ·(unknown), (unknown), Tapio Hellman, Niina Koivuviita, Jussi P. Pärkkä, (unknown), Kaj Metsärinne, Mikko J. Järvisalo	2
6	Interatrial block, P terminal force or fragmented QRS do not predict new-onset atrial fibrillation in patients with severe chronic kidney disease 2020 ·BMC Cardiovascular Disorders ·Tapio Hellman, (unknown), (unknown), Niina Koivuviita, Jussi P. Pärkkä, (unknown), Tuomas Kiviniemi, Juhani Airaksinen, Mikko J. Järvisalo, Kaj Metsärinne	4
7	The renal blood flow reserve in healthy humans and patients with atherosclerotic renovascular disease measured by positron emission tomography using [15O]H2O 2018 ·EJNMMI Research ·(unknown), Niina Koivuviita, Vesa Oikonen, Hidehiro Iida, (unknown), (unknown), Eliisa Löyttyniemi, Pirjo Nuutila, Kaj Metsärinne	11
8	The effect of revascularization of renal artery stenosis on renal perfusion in patients with atherosclerotic renovascular disease 2012 ·Nephrology Dialysis Transplantation ·Niina Koivuviita, (unknown), Nobuyuki Kudomi, Vesa Oikonen, Risto Tertti, (unknown), Tero Vahlberg, Pirjo Nuutila, Kaj Metsärinne	18
9	Amino-acid-based peritoneal dialysis solution improves amino-acid transport into skeletal muscle 2008 ·Kidney International ·Markku Asola, Kirsi A. Virtanen, Kjell Någren, Semi Helin, Markku Taittonen, Helena Kastarinen, Björn Anderstam, Juhani Knuuti, Kaj Metsärinne, Pirjo Nuutila	15
10	Asbestos-related pleural and lung fibrosis in patients with retroperitoneal fibrosis 2008 ·Orphanet Journal of Rare Diseases ·(unknown), Ritva Järvenpää, (unknown), Anssi Auvinen, Eero Honkanen, Kaj Metsärinne, Pekka Roto, Heikki Saha, Jukka Uitti, Panu Oksa	6
11	Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites 2007 ·British Journal of Clinical Pharmacology ·Miia Turpeinen, Niina Koivuviita, Ari Tolonen, Petri Reponen, Stefan Lundgren, Jouko Miettunen, Kaj Metsärinne, Anders Rane, Olavi Pelkonen, Kari Laine	34
12	Value of Electron Microscopy in Kidney Biopsy Diagnosis 2005 ·Ultrastructural Pathology ·Yrjö Collan, Pirkko Hirsimäki, H. Aho, Maarit Wuorela, Johan Sundström, Risto Tertti, Kaj Metsärinne	20
13	Asbestos exposure as a risk factor for retroperitoneal fibrosis 2004 ·The Lancet ·(unknown), Panu Oksa, Anssi Auvinen, Eero Honkanen, Kaj Metsärinne, Heikki Saha, Jukka Uitti, Pekka Roto	123
14	Degradation of endothelin-1 by extracts of rat lung, kidney, and liver 1995 ·Regulatory Peptides ·(unknown), O. Saijonmaa, Kaj Metsärinne, Frej Fyhrquist	7
15	The Effect of Aortic Coarctation on Expression of Endothelin-1 and Endothelin Receptors in Heart and Lungs 1995 ·Blood Pressure ·(unknown), (unknown), (unknown), Kaj Metsärinne, Frej Fyhrquist	3
16	Effects of prolonged tourniquet ischaemia and short-term venous stasis on plasma endothelin-1 levels in man 1995 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Kaj Metsärinne, (unknown), Seppo Santavirta, A Kauste, I. Tikkanen, Frej Fyhrquist	1
17	Immunoreactive interleukin‐6 in serum of patients with B‐lymphoproliferative diseases 1992 ·Journal of Internal Medicine ·Tom Pettersson, Kaj Metsärinne, A M Teppo, Frej Fyhrquist	10
18	Tissue distribution and half-life of 125 I-endothelin in the rat: Importance of pulmonary clearance 1990 ·Biochemical and Biophysical Research Communications ·(unknown), Kaj Metsärinne, Outi Saijonmaa, Frej Fyhrquist	93
19	Renin substrate in human amniotic fluid 1989 ·Clinica Chimica Acta ·Kaj Metsärinne, Frej Fyhrquist, Katarina Rosenlöf, Matti Autero, Fredrika Pekonen, Eeva‐Marja Rutanen	1
20	Direct radio-immunoassay of renin substrate: Effect of converting enzyme inhibition 1988 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Kaj Metsärinne, Katarina Rosenlöf, Carola Grönhagen‐Riska, F Fyhrquist	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact